The clinical spectrum of thrombotic thrombocytopenic purpura

Seminars in Thrombosis and Hemostasis

Volumn 31, Issue 6, 2005, Pages 673-680

  Kwaan, Hau C ^a   Boggio, Lisa N ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

ADAMTS13; Hemolytic uremic syndrome; Plasma exchange; Thrombotic microangiopathy; Thrombotic thrombocytopenic purpura

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

CLINICAL FEATURE; DIAGNOSTIC ACCURACY; FEVER; HEMOLYTIC ANEMIA; HEMOLYTIC UREMIC SYNDROME; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DISEASE; NEUROLOGIC DISEASE; PATHOGENESIS; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ANEMIA, HEMOLYTIC; DIAGNOSIS, DIFFERENTIAL; FEVER; HUMANS; KIDNEY DISEASES; MICROCIRCULATION; NERVOUS SYSTEM DISEASES; PURPURA, THROMBOTIC THROMBOCYTOPENIC; SYNDROME;

EID: 30344466944     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-925473     Document Type: Review

References (56)

1. Symmers WC. Thrombotic microangiopathic haemolytic anaemia. Br J Haematol 1952;2:897-903
2. Moschcowitz E. Hyaline thrombosis of the terminal arterioles and capillaries: a hitherto undescribed disease. Proc NY Pathol Soc 1924;24:21-24
3. Baehr G, Klemperer P, Schlifrin A. An acute febrile anaemia and thrombotic purpura with diffuse platelet thrombosis of capillaries and arterioles. Trans Assoc Am Physicians 1936; 51:43-58
4. Asada Y, Sumiyoshi A, Hayashi T, Suzumiya J, Kaketani K. Immunohistocytochemistry of vascular lesion in thrombocytopenic thrombocytopenic purpura with special reference to factor VIII related antigen. Thromb Res 1985;38:469-479
5. Ridolfi RL, Bell WR. Thrombotic thrombocytopenic purpura: a report of 25 cases and a review of the literature. Medicine (Baltimore) 1981;60:413-428
6. Hosler GA, Cusumano AM, Hutchins GM. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome are distinct pathologic entities. A review of 56 autopsy cases. Arch Pathol Lab Med 2003;127:834-839
7. Shidham VB, Chang CC, Schidham G, et al. Colon biopsies for evaluation of acute graft-versus-host disease (AGVHD) in allogenic bone marrow transplant patients. BMC Gastroenterol 2003;3:5-XX
8. Blecher TE, Roper AB. Early diagnosis of thrombotic microangiopathy by paraffin sections of aspirated bone marrow. Arch Dis Child 1967;42:158-162
9. Petitt RM. Thrombotic thrombocytopenic purpura: A thirty year review. Semin Thromb Hemost 1980;6:350-355
10. Rossi E. Thrombotic thrombocytopenic purpura. In: Wu K, ed. Pathophysiology and Management of Thromboembolic Disorders. Littleton, MA;1984:219-231
11. Kwaan HC. The pathogenesis of thrombotic thrombocytopenic purpura. Semin Thromb Hemost 1979;5:184-198
12. Torok TJ, Holman RC, Chorba TI. Increasing mortality from thrombotic thrombocytopenic purpura in the United States: analysis of national mortality data, 1969-1991. Am J Hematol 1995;50:84-90
13. Miller DP, Kaye JA, Shea K, et al. Incidence of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome. Epidemiology 2004;15:208-215
14. Terrell DR, Williams LA, Vesely SK, et al. The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients and patients with severe ADAMTS-13 deficiency. J Thromb Haemost 2005;3: 1432-1436
15. Kennedy SS, Zacharski LR, Beck JR. Thrombotic thrombocytopenic purpura: analysis of 48 unselected cases. Semin Thromb Hemost 1980;6:341-349
16. Raife TJ, Lentz SR, Atkinson BS, Vesely SK, Hessner MJ. Factor V Leiden: a genetic risk factor for thrombotic microangiopathy in patients with normal von Willebrand factor-cleaving protease activity. Blood 2002;99:437-442
17. Hymes KB, Karpatian S. Immunodeficiency virus infection and thrombotic microangiopathy. Semin Hematol 1997;34: 117-125
18. Novitzky N, Thomson J, Abrahams L, du Toit C, McDonald A. Thrombotic thrombocytopenic purpura in patients with retroviral infection is highly responsive to plasma infusion therapy. Br J Haematol 2005;128:373-379
19. Sahud MA, Claster S, Liu L, et al. Von Willebrand factor-cleaving protease inhibitor in a patient with human immunodeficiency syndrome-associated thrombotic thrombocytopenic purpura. Br J Haematol 2002;116:909-911
20. Gruszecki AC, Wehrli G, Ragland BD, et al. Management of a patient with HIV infection-induced anemia and thrombocytopenia who presented with thrombotic thrombocytopenic purpura. Am J Hematol 2002;69:228-231
21. Nicol KK, Shelton BJ, Knovich MA, Owen J. Overweight individuals are at increased risk for thrombotic thrombocytopenic purpura. Am J Hematol 2003;74:170-174
22. Ducloy-Bouthers AS, Caron C, Subtil D, et al. Thrombotic thrombocytopenic purpura and biological monitoring of six pregnancies. Eur J Obstet Gynecol Reprod Biol 2003;111: 146-152
23. Amorosi EL, Ultmann JE. Thrombotic thrombocytopenic purpura: Report of 16 cases and review of the literature. Medicine (Baltimore) 1966;45:139-159
24. Lukes RJ, Rath CE, Steussy CN, et al. Thrombotic thrombocytopenic purpura: Clinical and pathologic findings in 49 cases. Blood 1961;17:366 (abst)
25. Bukowski R. Thrombotic thrombocytopenic purpura: a review. Prog Hemost Thromb 1982;6:287-337
26. Kwaan HC, Domer PH. Fatal thrombotic thrombocytopenic purpura despite plasmaphersis. A case report of autopsy findings. Haemostasis 1989;19:344-347
27. Park SA, Lee TK, Sung KB, Park SK. Extensive brain stem lesions in thrombocytopenic thrombocytopenic purpura: repeat magnetic resonance findings. J Neurol 2005;15: 79-81
28. D'Aprile P, Farchi G, Pagliarulo R, Carella A. Thrombotic thrombocytopenic purpura: MR demonstration of reversible brain abnormalities. AJNR Am J Neuroradiol 1994;15: 19-20
29. Blum AS, Drislane FW. Nonconvulsive status epilepticus in thrombotic thrombocytopenic purpura. Neuroimaging 1996; 47:1079-1081
30. Garrett WT, Chang CW, Bleck TP. Altered mental status in thrombotic thrombocytopenic purpura is secondary to non-convulsive status epilepticus. Ann Neurol 1996;40: 245-246
31. Mecozzi G, Milano AD, De Carlo M, et al. Intravascular hemolysis in patients with new-generation prosthetic heart valves: a prospective study. J Thorac Cardiovasc Surg 2002; 123:550-556
32. Zomas A, Saso R, Powles R, et al. Red cell fragmentation (schistocytosis) after bone marrow transplantation. Bone Marrow Transplant 1998;22:777-780
33. Atkins JN, Muss HB. Schistocytes in erthroleukemia. Am J Med Sci 1985;289:110-113
34. Burns ER, Lou Y, Pathak A. Morphologic diagnosis of thrombotic thrombocytopenic purpura. Am J Hematol 2004;75:18-21
35. Daram SR, Philipneri M, Puri N, Bastani B. Thrombotic thrombocytopenic purpura without schistocytes on the peripheral blood smear. South Med J 2005;98:392-395
36. Fava S, Galizia AC. Thrombotic thrombocytopenic purpura-like syndrome in the absence of schistocytes. Br J Haematol 1995;89:643-644
37. Brilliant SE, Lester PA, Ohno AK, et al. Hemolytic-uremic syndrome without evidence of microangiopathic hemolytic anemia on peripheral blood smear. South Med J 1996;89:342-345
38. Lee J-L, Lee J-H, Kim M-K, et al. A case of bone marrow necrosis with thrombotic thrombocytopenic purpura as a manifestation of occult colon cancer. Jpn J Clin Oncol 2004; 34:476-480
39. Remuzzi G, Galbusera M, Salvsdori M, et al. Bilateral nephrectomy stopped disease progression in plasma-resistant hemolytic uremic syndrome with neurological signs and coma. Kidney Int 1996;49:282-286
40. Kwaan HC. Clinicopathologic features of thrombotic thrombocytopenic purpura. Semin Hematol 1987;24:71-81
41. Muniz AE, Barbee RW. Thrombotic thrombocytopenic purpura (TTP) presenting as pancreatitis. J Emerg Med 2003;24:407-411
42. Singh R, Saunders B, Scopelitis E. Pancreatitis leading to thrombotic thrombocytopenic purpura in systemic lupus erythematosus: a case report and review of literature. Lupus 2003;12:136-139
43. Talwalkar JA, Ruymann FW, Marcoux P, Farraye FA. Recurrent thrombotic thrombocytopenic purpura (TTP) as a complication of acute relapsing pancreatitis. Dig Dis Sci 2002;47:1096-1099
44. Varadarajulu S, Ramsey WH, Israel RH. Thrombotic thrombocytopenic purpura in acute pancreatitis. J Clin Gastroenterol 2000;31:243-245
45. Vergara M, Modolell I, Puig-Divi V, Guarner L, Malagelada JR. Acute pancreatitis as triggering factor for thrombotic thrombocytopenic purpura. Am J Gastroenterol 1998;93: 2215-2218
46. Berlin I, Sinclair CL, Richman LJ, et al. Thrombotic thrombocytopenic purpura. Va Med Monthly 1957;84:293-295
47. Chung EB, Gomez-Acebo J. Thrombotic thrombocytopenic purpura: a report of two cases with some unusual features. Georgetown Med Bull 1960;14:137-141
48. Comess OH, Oyamada A. Uremic and disseminated platelet-cell thrombosis. Arch Intern Med 1952;89:802-811
49. Geisinger KR, Solomon AR. Sudden cardiac death in thrombotic thrombocytopenic purpura. Arch Pathol Lab Med 1979;103:599 (letter)
50. James TN, Monto RW. Pathology of the cardiac conduction system in thrombotic thrombocytopenic purpura. Ann Intern Med 1966;65:37-43
51. McCrae KR, Cines DB. Thrombotic microangiopathy during pregnancy. Semin Hematol 1997;34:148-158
52. Vesely SK, Li X, McMinn JR, Terrell DR, George JN. Pregnancy outcomes after recovery from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Transfus Pract 2004;44:1149-1158
53. Dashe JS, Ramin SM, Cunningham FG. The long term consequences of thrombotic microangiopathy (thrombotic thrombocytopenic purpura and hemolytic uremic syndrome) in pregnancy. Obstet Gynecol 1998;91:662-668
54. Veyradier A, Obert B, Houllier A, Meyer D, Gima J-P. Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases. Blood 2001; 98:1765-1772
55. Zheng XL, Kaufman RM, Goodnough LT, Sadler JE. Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and nonidiopathic thrombotic thrombocytopenic purpura. Blood 2004;103:4043-4049
56. George JN, Li X, McMinn JR, et al. Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic HPC transplantation: a diagnostic dilemma. Transfusion 2004;44:294-304